XPHState Street SPDR S&P Pharmaceuticals ETF
Grow my money#556 of 2944 for Grow my money
Seeks to provide investment results that correspond generally to the total return performance of an index derived from the pharmaceuticals segment.
State Street Investment Management · Since 2006 (19 years)
Annual Cost
0.35%
#1517 out of 5,332 ETFs
Fund Size
$308M
#1787 out of 5,332 ETFs
Dividend Yield
0.69%
Track Record
19 years
#338 out of 5,332 ETFs
Performance
1 Year
+43.0%
3 Years
+13.7%
5 Years
+4.4%
What's inside
Asset class
Region
Focus
Pharmaceuticals
Asset allocation
Stocks
99.9%
Cash
0.1%
Sector breakdown
Healthcare
100.0%
Top holdings
Enliven Therapeutics IncELVN2.4%
Corcept Therapeutics IncCORT2.3%
Terns Pharmaceuticals Inc Ordinary SharesTERN2.2%
Perrigo Co PLCPRGO2.1%
Axsome Therapeutics IncAXSM2.0%
Innoviva IncINVA2.0%
Merck & Co IncMRK2.0%
Pfizer IncPFE2.0%
Royalty Pharma PLC Class ARPRX2.0%
Elanco Animal Health IncELAN2.0%
Risk profile
Volatility (1Y)
21.7%
High
Max drawdown
-36.0%
Worst peak-to-trough loss
Sharpe (3Y)
0.57
Decent risk-adjusted returns
Sortino (3Y)
0.83
Moderate downside risk
Similar ETFs
Data updated on 2026-05-05